Cathay AfricInvest Innovation invests in African genomics startup 54gene

Cathay AfricInvest Innovation leads round as company expands precision medicine capabilities across the African continent WASHINGTON, Sept. 16, 2021 — 54gene, the health technology company advancing African genomics research for improved global health outcomes, has secured $25M in a Series B round, led by Cathay AfricInvest Innovation Fund. The round also included participation from Adjuvant Capital, KdT Ventures, Plexo Capital, Endeavor Capital, Ingressive Capital and others. […]

Read More…